ZPHC Retatrutide 10 mg

ZPHC Retatrutide 10 mg — Weight loss

ZPHC Retatrutide 10 mg is an investigational multi-receptor incretin peptide designed to promote weight loss and improve metabolic markers. It’s administered as a weekly subcutaneous injection.

What it does

Retatrutide acts on three pathways (GLP-1, GIP, and GCGR) to reduce your appetite, increase feelings of fullness, boost energy expenditure, and improve metabolic control — leading to meaningful weight loss.

How to use it

• Dosing schedule: Start at a lower dose (2.5–5 mg weekly) and increase gradually to 5–10 mg once weekly as tolerated. Most users aim for 10 mg weekly.
• Duration: Typically 12–24 weeks or longer depending on your results.
• Administration: Inject under the skin once per week using sterile technique; follow storage instructions.

Getting the best results

Retatrutide works best when combined with healthy eating and regular physical activity. Eat smaller meals and stay well hydrated, especially during the first few weeks when your body is adjusting. You should expect progressive weight loss over the weeks ahead. Gradual dose increases help minimize nausea and other digestive side effects.

Side effects to expect

Common: Nausea, vomiting, diarrhea, constipation, and decreased appetite — most improve as your body adjusts.

Serious (rare): Severe abdominal pain (pancreatitis), gallbladder problems, rapid heartbeat, or signs of allergic reaction. Stop use immediately if you experience any of these.

Important safety information

Do not use if you are pregnant or breastfeeding. Use caution if you have a personal or family history of thyroid cancer or MEN2 syndrome. Be aware of potential interactions with other medications and existing health conditions. Stay hydrated to avoid kidney problems from severe vomiting or dehydration.

We recommend using our peptide dosage & reconstitution calculators.